Memphis, TN, United States of America

Richard Kriwacki

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Richard Kriwacki: Innovator in Cancer Research**

Introduction

Richard Kriwacki is a prominent inventor based in Memphis, TN, known for his significant contributions to the field of cancer research. With a total of six patents to his name, his work primarily focuses on developing novel compounds that target specific proteins involved in cancer progression.

Latest Patents

Among his latest inventions is a series of aryl-substituted imidazoles. These compounds serve as antagonists of MDM2 and MDMX, demonstrating excellent specificity for these proteins over others. Notably, they exhibit selective binding affinity to MDMX compared to MDM2, making them valuable in regulating p53 activity. This property enables the potential treatment of various types of cancers. The abstract associated with these patents serves as a searching tool within the relevant scientific area and does not limit the broader scope of the invention.

Career Highlights

Richard Kriwacki is affiliated with St. Jude Children's Research Hospital, a leading institution dedicated to treating pediatric catastrophic diseases. His contributions to cancer research have positioned him as a key player in the development of innovative therapies for children facing cancer.

Collaborations

Throughout his career, Kriwacki has collaborated with esteemed colleagues, including R Kiplin Guy and Yiqun Zhang. These partnerships have further enhanced the research and development of groundbreaking solutions in the fight against cancer.

Conclusion

Richard Kriwacki exemplifies the spirit of innovation in the field of medical research. His work at St. Jude Children's Research Hospital, along with his impressive patent portfolio, underscores his commitment to advancing cancer treatment. As he continues to develop new compounds, his impact on the medical community and patients worldwide is undeniable.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…